About VasoGlobal

VasoMedical Global Corp. (VasoGlobal), has been established to manage the operations of the Company's recently acquired Chinese companies, as well as to identify and manage potential accretive acquisitions the Company may consider.

“The completion of our accretive acquisitions is an important step of our global strategy. The consolidation of resources and vertical integration of our businesses situates VasoMedical well in the rapidly changing and challenging medical marketplace to realize its vision to be a global leader.” Dr. Jun Ma, President & CEO of Vaso Corporation

About VasoMedical

VasoMedical, Inc. is a global leader in non-invasive healthcare solutions and products with corporate offices in Plainview, New York. We also have manufacturing facilities in China and sales operations in North Carolina. Our proprietary core product line of Enhanced External Counterpulsation (EECP^®) Therapy systems is the leading product in the non-invasive treatment of cardiovascular disease. VasoMedical is the parent company of our operating subsidiaries - VasoMedical Global and VasoHealthcare. The Company is pursuing a strategy of accretive acquisitions in the medical device and health care markets and promoting growth in our core businesses.

Click here to visit the VasoMedical website

---